<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3175</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Informative analysis of quality of life after various technologies of treatment of uterine myoma</article-title><trans-title-group xml:lang="ru"><trans-title>Информативность анализа качества жизни после различных технологий лечения миомы матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bashirov</surname><given-names>E V</given-names></name><name xml:lang="ru"><surname>Баширов</surname><given-names>Эдуард Владимирович</given-names></name></name-alternatives><bio xml:lang="en">Department of obstetrics, gynecology and perinatology</bio><bio xml:lang="ru">Кафедра акушерства, гинекологии и перинатологии</bio><email>edikbashirov@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kutsenko</surname><given-names>I I</given-names></name><name xml:lang="ru"><surname>Куценко</surname><given-names>Ирина Игоревна</given-names></name></name-alternatives><bio xml:lang="en">Department of obstetrics, gynecology and perinatology</bio><bio xml:lang="ru">Кафедра акушерства, гинекологии и перинатологии</bio><email>edikbashirov@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Polina</surname><given-names>M L</given-names></name><name xml:lang="ru"><surname>Полина</surname><given-names>Мирослава Леонидовна</given-names></name></name-alternatives><bio xml:lang="en">Department of obstetrics-gynecology and reproductive medicine</bio><bio xml:lang="ru">Кафедра акушерства, гинекологии и репродуктивной медицины</bio><email>polina.ml@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kuban state medical university</institution></aff><aff><institution xml:lang="ru">Кубанский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2015</year></pub-date><issue>1</issue><issue-title xml:lang="en">NO1 (2015)</issue-title><issue-title xml:lang="ru">№1 (2015)</issue-title><fpage>77</fpage><lpage>84</lpage><history><date date-type="received" iso-8601-date="2016-09-07"><day>07</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="ru">Copyright ©; 2015, Баширов Э.В., Куценко И.И., Полина М.Л.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Баширов Э.В., Куценко И.И., Полина М.Л.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/3175">https://journals.rudn.ru/medicine/article/view/3175</self-uri><abstract xml:lang="en">This study was performed to evaluate symptoms of uterine fibroid and their impact on the quality of life after treatment using a validated questionnaire. It is shown that the assessment of quality of life not only a predictor of the complicated postoperative period and the remote recurrence of a disease, as well as the criterion of full course of rehabilitation. Preference of UAE leads to sustained improvement in the quality of life and to a significant relief of symptoms with the greatest recovery after comprehensive rehabilitation.</abstract><trans-abstract xml:lang="ru">Это исследование было выполнено для оценки симптомов миомы матки и их влияния на качество жизни после лечения с использованием эффективного опросника. Показано, что оценка качества жизни не только предиктор осложненного течения послеоперационного периода и отдаленных рецидивов заболевания, а также критерия полноценности курса реабилитации. Предпочтение ЭМА приводит к устойчивому улучшению качества жизни и к существенному облегчению симптомов с наибольшим восстановлением после комплексной реабилитации.</trans-abstract><kwd-group xml:lang="en"><kwd>uterine myoma</kwd><kwd>organ-preserving interventions</kwd><kwd>comprehensive rehabilitation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>миома матки</kwd><kwd>органосохраняющие вмешательства</kwd><kwd>комплексная реабилитация</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине. М.: ОЛМА Медиагруп, 2007.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Савельева Г.М., Бреусенко В.Г., Капранов С.А. и др. Эмболизация маточных артерий в лечении миомы матки: достижения и перспективы // Акушерство и гинекология. 2007. № 5. С. 54-59.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Савельева Г.М., Курцер М.А., Бреусенко В.Г. и др. Эндоскопическая миомэктомия: за и против // Вопросы акушерства, гинекологии и перинатологии. 2007. Т. 6. № 1. С. 57-60.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Coyne K.S., Margolis M.K., Murphy J. et al. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research // Value Health. 2012. V. 15. N 5. P. 674-679.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fennessy F.M., Kong C.Y., Tempany C.M. et al. Quality-of-life assessment of fibroid treatment options and outcomes // Radiology. 2011. V. 259. N 3. P. 785-792.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Froeling V., Scheurig-Muenkler C., Steffen I.G. et al. Change in health-related quality of life and change in clinical symptoms after uterine artery embolization in patients with symptomatic adenomyosis uteri - evaluation using a standardized questionnaire // Rofo. 2012. V. 184. N 1. P. 48-52.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Goodwin S.C., Spies J.B., Worthington-Kirsch R. et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry // Obstet Gynecol. 2008. V. 111. N 1. P. 22-33.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gupta J.K., Sinha A., Lumsden M.A. et al. Uterine artery embolization for symptomatic uterine fibroids // Cochrane Database Syst Rev. 2012. V. 16. N 5. CD005073.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Parker W.H. Laparoscopic myomectomy and abdominal myomectomy // Clin Obstet Gynecol. 2006. V. 49. N 4. P. 789-797.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Popovic M., Puchner S., Berzaczy D. et al. Uterine artery embolization for the treatment of adenomyosis: a review // J Vasc Interv Radiol. 2011. V. 22. N 7. P. 901-909.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Scheurig-Muenkler C., Lembcke A., Froeling V. et al. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life // Hum Reprod. 2011. V. 26. N 8. P. 2036-2042.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shveiky D., Iglesia C.B., Antosh D.D. et al. The effect of uterine fibroid embolization on lower urinary tract symptoms // Int Urogynecol J. 2013. V. 24. N 8. P. 1341-1345.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Smeets A.J., Nijenhuis R.J., Boekkooi P.F. et al. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis // Cardiovasc Intervent Radiol. 2012. V. 35. N 4. P. 815-819.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Spies J.B., Bradley L.D., Guido R. et al. Outcomes from leiomyoma therapies: comparison with normal controls // Obstet Gynecol. 2010. V. 116. N 3. P. 641-652.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Spies J.B., Myers E.R., Worthington-Kirsch R. et al. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy // Obstet Gynecol. 2005. V. 106. N 6. P. 1309-1318.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Van der Kooij S.M., Ankum W.M., Hehenkamp W.J. Review of nonsurgical/minimally invasive treatments for uterine fibroids // Curr Opin Obstet Gynecol. 2012. V. 24. N 6. P. 368-375.</mixed-citation></ref></ref-list></back></article>
